Literature DB >> 24783620

[Video-laryngoscope (McGRATH MAC): a clinical assessment of its performance in consecutive 100 patients].

Takero Arai, Hiroaki Suzuki, Katsumi Ogawa, Tomoyuki Saito, Yuichi Hashimoto, Mutsuhisa Shimazaki, Takashi Asai, Yasuhisa Okuda.   

Abstract

BACKGROUND: The McGRATH MAC Video laryngoscope (Covidien Japan) is a relatively new device for tracheal intubation, which provides an excellent glottis view. We here report the clinical experience of the McGRATH in 100 patients who received general anesthesia.
METHODS: Tracheal intubation with the McGRATH was performed in 100 patients requiring oro/naso tracheal intubation. The view of glottic opening was scored according to the classification of Cormack-Lehane. The time required to intubate and the number of intubation attempts were recorded.
RESULTS: Cormack-Lehane classification 1 or 2 was obtained in 99 of 100 patients, respectively, and successful intubation was achieved in all patients. The mean +/- SD time to successful intubation was 40 +/- 19 seconds.
CONCLUSIONS: The McGRATH was easily handled not only by experienced anesthetists but also by novice personnel. The McGRATH seems to be a useful device in routine and difficult airway management.

Entities:  

Mesh:

Year:  2014        PMID: 24783620

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Intubation without use of stylet for McGrath videolaryngoscopy in patients with expected normal airway: A randomized noninferiority trial.

Authors:  Hyun Jeong Kwak; Sook Young Lee; Su Youn Lee; Yong Beom Kim; Jong Yeop Kim
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

2.  The usefulness of the McGrath MAC laryngoscope in comparison with Airwayscope and Macintosh laryngoscope during routine nasotracheal intubation: a randomaized controlled trial.

Authors:  Aiji Sato Boku; Kazuya Sobue; Eisuke Kako; Naoko Tachi; Yoko Okumura; Mayuko Kanazawa; Mayumi Hashimoto; Jun Harada
Journal:  BMC Anesthesiol       Date:  2017-12-01       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.